Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Intensive Care Management and Outcomes In Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Etienne Lengliné, MD, anne-Sophie Moreau, MD, Sylvie Chevret, MD, PhD, Frederic Pene, MD, PhD, François Blot, MD, Jean-Henri Bourhis, MD, Agnes Buzyn, MD, PhD, Benoît Schlemmer, MD, PhD, Gérard Socié, MD, PhD, Elie Azoulay, MD, PhD

Blood (2013) 122 (21): 4560.

https://doi.org/10.1182/blood.V122.21.4560.4560

Published: 2013

Journal Articles

In Vivo Imaging Model of Multiple Myeloma and Its Cellular Interaction with the Bone Marrow Microenvironment

Judith Runnels, PhD, Alicia Carlson, PhD, Costas Pitsillides, PhD, Joel Spencer, PhD, Juwell Wu, Abdel kareem Azab, PhD, Aldo M. Roccaro, MD, PhD, Anne-Sophie Moreau, MD, Xavier Leleu, MD, PhD, Andrew Kung, MD, PhD, Scott J. Rodig, MD, PhD, Kenneth C Anderson, MD, Charles P. Lin, PhD, Irene M. Ghobrial, M.D.

Blood (2008) 112 (11): 647.

https://doi.org/10.1182/blood.V112.11.647.647

Published: 2008

Journal Articles

CXCR7 Regulates SDF-1 Induced Adhesion and Homing in Multiple Myeloma.

Nicholas Burwick, MD, Anne-Sophie Moreau, MD, Xiaoying Jia, Xavier Leleu, MD, PhD, Judith Runnels, Hai T. Ngo, Molly R. Melhem, Aldo M. Roccaro, MD, PhD, Abdel kareem Azab, PhD, Irene M. Ghobrial, M.D.

Blood (2008) 112 (11): 1674.

https://doi.org/10.1182/blood.V112.11.1674.1674

Published: 2008

Journal Articles

Early Response Using Serum Immunoglobulin Free Light Chain (sFLC) Measurement Predicts Response to Therapy in Waldenstrom Macroglobulinemia (WM)

Xavier Leleu, MD, PhD, Aldo M. Roccaro, MD, PhD, Renee Leduc, Stephanie Poulain, MD, Anne-Sophie Moreau, MD, Julie Gay, MD, Remy Dulery, MD, Paul G. Richardson, MD, Irene M. Ghobrial, MD

Blood (2008) 112 (11): 3755.

https://doi.org/10.1182/blood.V112.11.3755.3755

Published: 2008

Journal Articles

Gene Transcriptional Activity Analysis in the 6q Region in Waldenstrom Macroglobulinemia (WM) Using ChIP-on-Chip Technology

Xavier Leleu, MD, PhD, Fangxin Hong, PhD, Aldo M. Roccaro, MD, PhD, Xiaoying Jia, Antonio Sacco, Anne-Sophie Moreau, MD, Hai Ngo, Abdel kareem Azab, PhD, Feda Azab, Molly Melhem, Kenneth C. Anderson, MD, Irene M. Ghobrial, MD

Blood (2008) 112 (11): 628.

https://doi.org/10.1182/blood.V112.11.628.628

Published: 2008

Journal Articles

Resveratrol Exerts Antiproliferative Effect and Induces Apoptosis in Waldenstrom’s Macroglobulinemia.

Aldo Roccaro, MD, Xavier Leleu, MD, Anne-Sophie Moreau, MD, Antonio Sacco, Lian Xu, Evdoxia Hatjiharissi, MD, Bryan Ciccarelli, Christopher Patterson, Sophia Adamia, Domenico Russo, MD, Angelo Vacca, MD, Franco Dammacco, MD, Kenneth Anderson, MD, Irene Ghobrial, MD, Steven Treon, MD

Blood (2007) 110 (11): 1383.

https://doi.org/10.1182/blood.V110.11.1383.1383

Published: 2007

Journal Articles

Biological Sequelae of TRAF2 Downregulation in Waldenstrom Macroglobulinemia Cells.

Xavier Leleu, MD, Lian Xu, Zachary R. Hunter, Sophia Adamia, PhD, Evdoxia Hatjiharissi, MD, Anne-Sophie Moreau, MD, Aldo Roccaro, MD, Antonio Sacco, MD, Brian Ciccarelli, Robert J. Manning, Christopher J. Patterson, Irene M. Ghobrial, MD, Steven P. Treon, MD

Blood (2007) 110 (11): 3526.

https://doi.org/10.1182/blood.V110.11.3526.3526

Published: 2007

Journal Articles

Regulation of the New CXCR7 Receptor in Plasma Cell Dyscrasias.

Anne-Sophie Moreau, MD, Xavier Leleu, MD, Xiaoying Jia, Judith Runnels, PhD, Costas Pitsillides, Alicia L. Carlson, PhD, Hai T. Ngo, Aldo M. Roccaro, MD, Abdelkareem Azab, PhD, Feda Azab, Charles P. Lin, PhD, Irene M. Ghobrial, MD

Blood (2007) 110 (11): 3527.

https://doi.org/10.1182/blood.V110.11.3527.3527

Published: 2007

Journal Articles

Targeting NF-kB by Perifosine, Bortezomib and Rituximab in Waldenstrom Macroglobulinemia (WM).

Xavier Leleu, MD, Eeckhoute Jerome, PhD, Xiaoying Jia, Anne-Sophie Moreau, MD, Aldo M. Roccaro, MD, Mena Farag, Antonio Sacco, Evdoxia Hatjiharissi, MD, Hai T. Ngo, Judith Runnels, PhD, Abdelkareem Azab, PhD, Feda Azab, Zachary Hunter, Peter Sportelli, Steven P. Treon, MD, Teru Hideshima, MD, Kenneth C. Anderson, MD, Irene M. Ghobrial, MD

Blood (2007) 110 (11): 2512.

https://doi.org/10.1182/blood.V110.11.2512.2512

Published: 2007

Journal Articles

The Combination of Bortezomib and NPI-0052 Exerts Anti-Tumor Activity in Waldenstrom Macroglobulinemia (WM).

Aldo Roccaro, MD, Xavier Leleu, MD, Antonio Sacco, Xiaoying Jia, Anne-Sophie Moreau, MD, Hai Ngo, Abdelkareem Azab, Feda Azab, Evdoxia Hatjiharissi, MD, Steven Treon, MD, Teru Hideshima, MD, Michael Palladino, Kenneth Anderson, MD, Dharminder Chuahan, Irene Ghobrial, MD

Blood (2007) 110 (11): 1516.

https://doi.org/10.1182/blood.V110.11.1516.1516

Published: 2007

Journal Articles

Serum Immunoglobulin Free Light Chain (sFLC) Is a Sensitive Marker of Response in Waldenstrom Macroglobulinemia (WM).

Xavier Leleu, MD, Evdoxia Hatjiharissi, MD, Aldo M. Roccaro, MD, Anne-Sophie Moreau, MD, Renee Leduc, Marybeth Nelson, Mena Farag, Steven P. Treon, MD, Irene M. Ghobrial, MD

Blood (2007) 110 (11): 1486.

https://doi.org/10.1182/blood.V110.11.1486.1486

Published: 2007

Journal Articles

Hedgehog Pathway as a Potential Therapeutic Target in Multiple Myeloma.

Simona Blotta, MD, Joeseph Negri, Purushothama Nanjappa, Anne-Sophie Moreau, MD, Rao Prabhala, PhD, Masood Shammas, PhD, Dheeraj Pelluru, PhD, Douglas McMillin, PhD, Yu-Tzu Tai, PhD, Pierfrancesco Tassone, MD, Kenneth C. Anderson, MD, Constantine Mitsiades, MD, PhD, Nikhil C. Munshi, MD

Blood (2007) 110 (11): 672.

https://doi.org/10.1182/blood.V110.11.672.672

Published: 2007

Journal Articles

A Novel Real-Time In Vivo Homing Model of Multiple Myeloma.

Judith M. Runnels, PhD, Costas Pitsillides, PhD, Joel A. Spencer, Joji Fujisaki, PhD, Hai Ngo, Evdoxia Hatjiharissi, MD, Xavier Leleu, MD, Anne-Sophie Moreau, MD, Xiaoying Jia, Teru Hideshima, MD, Nikhil Munshi, MD, Kenneth C. Anderson, PhD, Charles P. Lin, PhD, Irene M. Ghobrial, MD

Blood (2006) 108 (11): 242.

https://doi.org/10.1182/blood.V108.11.242.242

Published: 2006

Journal Articles

Novel Agent Perifosine Enhances Antitumor Activity of Bortezomib, Rituximab and Other Conventional Therapies in Waldenstrom’s Macroglobulinemia.

Xavier Leleu, MD, Garrett O’Sullivan, Xiaoying Jia, Anne-Sophie Moreau, MD, Hai Ngo, Evdoxia Hatjiharisi, MD, Hiroshi Yasui, Zachary Hunter, Yu-Tsu Tai, PhD, Judith Runnels, PhD, Steven Treon, MD, Teru Hideshima, MD, Kenneth Anderson, MD, Irene Ghobrial, MD

Blood (2006) 108 (11): 2517.

https://doi.org/10.1182/blood.V108.11.2517.2517

Published: 2006

Journal Articles

Abnormal Expression of TRAF Adapter Proteins in Waldenstrom’s Macroglobulinemia.

Xavier Leleu, MD, Lian Xu, Zachary R. Hunter, Anne-Sophie Moreau, MD, Xiaoying Jia, Garrett O’Sullivan, Vinod Bakthavachalam, Allen W. Ho, Evdoxia Hatjiharissi, MD, Hai T. N’Go, Daniel D. Santos, MD, Kelly O’Connor, Robert Manning, Jacob Soumerai, Christopher Patterson, Irene M. Ghobrial, MD, Steven P. Treon, MD

Blood (2006) 108 (11): 4640.

https://doi.org/10.1182/blood.V108.11.4640.4640

Published: 2006

Journal Articles

Endoplasmic Reticulum Stress Is a Target for Therapy in Waldenstrom’s Macroglobulinemia (WM).

Xavier Leleu, MD, Lian Xu, Zachary R. Hunter, Xiaoying Jia, Anne-Sophie Moreau, MD, Allen W. Ho, Evdoxia Hatjiharissi, MD, Hai N’Go, Daniel D. Santos, MD, Kelly O’Connor, Robert Manning, Jacob Soumerai, Christopher Patterson, Irene M. Ghobrial, MD, Steven P. Treon, MD

Blood (2006) 108 (11): 4641.

https://doi.org/10.1182/blood.V108.11.4641.4641

Published: 2006

Journal Articles

Analysis of Chemokine and Adhesion Markers in Waldenstrom Macroglobulinemia.

Hai T. Ngo, Xavier Leleu, MD, Anne-Sophie Moreau, MD, Evdoxia Hatjiharissi, MD, Xiaoying Jia, Garrett O’Sullivan, Judith Runnels, PhD, Rose Villarreal, Zachary Hunter, Steven Treon, MD,PhD, Teru Hideshima, MD, Kenneth Anderson, MD, Irene Ghobrial, MD

Blood (2006) 108 (11): 4653.

https://doi.org/10.1182/blood.V108.11.4653.4653

Published: 2006

Journal Articles

The Combination of the mTOR Inhibitor Rapamycin and Proteasome Inhibitor Bortezomib Is Synergistic In Vitro in Multiple Myeloma.

Garrett O’Sullivan, Xavier Leleu, MD, Xiaoying Jia, Evdoxia Hatjiharisi, MD, Hai Ngo, Anne-Sophie Moreau, MD, Yu-Tsu Tai, PhD, Douglas McMillin, Constantine Mitsiades, MD, Noopur Raje, MD, Teru Hideshima, MD, Robert Schlossman, MD, Paul Richardson, MD, Nikhil Munshi, MD, Kenneth Anderson, MD, Irene Ghobrial, MD

Blood (2006) 108 (11): 3495.

https://doi.org/10.1182/blood.V108.11.3495.3495

Published: 2006

Journal Articles

The Proteasome Inhibitor NPI-0052 in Combination with Bortezomib Induces Antitumor Activity in Waldenstrom Macroglobulinemia.

Xiaoying Jia, Xavier Leleu, MD, Anne-Sophie Moreau, MD, Evdoxia Hatjiharisi, MD, Hai Ngo, Garrett O’Sullivan, Douglas McMillin, PhD, Steven Treon, MD, Constantine Mitsiades, MD, Teru Hideshima, MD, Michael Palladino, Kenneth Anderson, MD, Dharminder Chauhan, PhD, Irene Ghobrial, MD

Blood (2006) 108 (11): 4746.

https://doi.org/10.1182/blood.V108.11.4746.4746

Published: 2006

Journal Articles

Abnormalities in Lipoprotein Metabolism Provide Insight into Novel Therapeutic Approaches for Waldenstrom’s Macroglobulinemia (WM).

Christopher J. Patterson, BS, Anne Sophie Moreau, MD, Xavier Leleu, MD, Jacob Soumerai, BS, Zachary Hunter, BS, Evdoxia Hatjiharissi, MD, Lian Xu, BS, Steven Treon, MD, PhD

Blood (2006) 108 (11): 4749.

https://doi.org/10.1182/blood.V108.11.4749.4749

Published: 2006

NARROW

Intensive Care Management and Outcomes In Allogeneic Hematopoietic Stem Cell Transplantation Recipients

In Vivo Imaging Model of Multiple Myeloma and Its Cellular Interaction with the Bone Marrow Microenvironment

CXCR7 Regulates SDF-1 Induced Adhesion and Homing in Multiple Myeloma.

Early Response Using Serum Immunoglobulin Free Light Chain (sFLC) Measurement Predicts Response to Therapy in Waldenstrom Macroglobulinemia (WM)

Gene Transcriptional Activity Analysis in the 6q Region in Waldenstrom Macroglobulinemia (WM) Using ChIP-on-Chip Technology

Resveratrol Exerts Antiproliferative Effect and Induces Apoptosis in Waldenstrom’s Macroglobulinemia.

Biological Sequelae of TRAF2 Downregulation in Waldenstrom Macroglobulinemia Cells.

Regulation of the New CXCR7 Receptor in Plasma Cell Dyscrasias.

Targeting NF-kB by Perifosine, Bortezomib and Rituximab in Waldenstrom Macroglobulinemia (WM).

The Combination of Bortezomib and NPI-0052 Exerts Anti-Tumor Activity in Waldenstrom Macroglobulinemia (WM).

Serum Immunoglobulin Free Light Chain (sFLC) Is a Sensitive Marker of Response in Waldenstrom Macroglobulinemia (WM).

Hedgehog Pathway as a Potential Therapeutic Target in Multiple Myeloma.

A Novel Real-Time In Vivo Homing Model of Multiple Myeloma.

Novel Agent Perifosine Enhances Antitumor Activity of Bortezomib, Rituximab and Other Conventional Therapies in Waldenstrom’s Macroglobulinemia.

Abnormal Expression of TRAF Adapter Proteins in Waldenstrom’s Macroglobulinemia.

Endoplasmic Reticulum Stress Is a Target for Therapy in Waldenstrom’s Macroglobulinemia (WM).

Analysis of Chemokine and Adhesion Markers in Waldenstrom Macroglobulinemia.

The Combination of the mTOR Inhibitor Rapamycin and Proteasome Inhibitor Bortezomib Is Synergistic In Vitro in Multiple Myeloma.

The Proteasome Inhibitor NPI-0052 in Combination with Bortezomib Induces Antitumor Activity in Waldenstrom Macroglobulinemia.

Abnormalities in Lipoprotein Metabolism Provide Insight into Novel Therapeutic Approaches for Waldenstrom’s Macroglobulinemia (WM).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only